Prevention and treatment of cardiovascular disease: the problem of compliance to recommendations

A. Korzh


The compliance to drug treatment is the ability to the beginning of therapy, the correct implementation of the regime and consistency in the implementation of the prescribed dosing regimen. Lack of commitment leads to serious consequences, increasing the adverse clinical outcomes and costs in the health care system respectively. In this case, the lack of complience can be divided into intentional, when the patient does not want to carry out medical advice, and involuntary, when in spite of the patient desire, there are practical problems in following the guidelines. Demonstrated the ability of various treatments to improve adherence to treatment through the use of communication strategies, such as motivational interviewing and coaching, simplification of the use of drugs, as well as improving quality at the system level.


cardiovascular diseases; prevention; compliance


Hobbs F.D.R., Erhardt L. Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the reassessing European attitudes about cardiovascular treatment (REACT) survey // Fam. Pract.-2002.-Vol.19.-P.596-604.

Vrijens B., Vincze G., Kristano P. et al. Adherence to prescribed anti-hypertensive drug treatments: longitudinal study of electronically compiled dosing histories // BMJ.-2008.-Vol.336.-P.1114-1117.

Di Matteo M.R., Giordani P.J., Lepper H.S. et al. Patient adherence and medical treatment outcomes: a meta analysis // Med. Care.-2002.-Vol.40.-P.794-811.

Copyright (c) 2018 Health of Society

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.


© Publishing House Zaslavsky, 1997-2019